Advertisement
Screener

Canopy Growth Corp (CGC) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Canopy Growth Corp Stock-Based Compensation

Canopy Growth Corp (CGC) reported Stock-Based Compensation of CAD 1.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-07

  • Canopy Growth Corp share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was 1.36M CAD.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was 1.47M CAD.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was 888.00K CAD, a 82.79% decline year-over-year.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was 2.01M CAD, a 61.52% decline year-over-year.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for fiscal 2026 was 4.27M CAD.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for fiscal 2025 was -4.21M CAD, a 129.65% decline from fiscal 2024.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for fiscal 2024 was 14.18M CAD, a 44.00% decline from fiscal 2023.
  • Canopy Growth Corp share-based payment arrangement, noncash expense for fiscal 2023 was 25.32M CAD, a 45.76% decline from fiscal 2022.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-301.36M CAD
10-Q · filed 2026-08-07
2.83M CAD
derived: sum of 2 quarters · filed 2026-08-07
3.71M CAD
derived: sum of 3 quarters · filed 2026-08-07
5.72M CAD
derived: sum of 4 quarters · filed 2026-08-07
2026-03-311.47M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
2.36M CAD
derived: sum of 2 quarters · filed 2026-06-15
4.37M CAD
derived: sum of 3 quarters · filed 2026-06-15
4.27M CAD
10-K · filed 2026-06-15
2025-12-31888.00K CAD
10-Q · filed 2026-02-06
2.90M CAD
derived: sum of 2 quarters · filed 2026-02-06
2.80M CAD
10-Q · filed 2026-02-06
-15.94M CAD
derived: sum of 4 quarters · filed 2026-08-07
2025-09-302.01M CAD
10-Q · filed 2025-11-07
1.91M CAD
10-Q · filed 2025-11-07
-16.83M CAD
derived: sum of 3 quarters · filed 2026-08-07
-11.67M CAD
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-99.00K CAD
10-Q · filed 2026-08-07
-18.84M CAD
derived: sum of 2 quarters · filed 2026-08-07
-13.68M CAD
derived: sum of 3 quarters · filed 2026-08-07
-8.46M CAD
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-18.74M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
-13.58M CAD
derived: sum of 2 quarters · filed 2026-06-15
-8.36M CAD
derived: sum of 3 quarters · filed 2026-06-15
-4.21M CAD
10-K · filed 2026-06-15
2024-12-315.16M CAD
10-Q · filed 2026-02-06
10.38M CAD
derived: sum of 2 quarters · filed 2026-02-06
14.53M CAD
10-Q · filed 2026-02-06
18.58M CAD
derived: sum of 4 quarters · filed 2026-06-15
2024-09-305.22M CAD
10-Q · filed 2025-11-07
9.37M CAD
10-Q · filed 2025-11-07
13.43M CAD
derived: sum of 3 quarters · filed 2026-06-15
17.12M CAD
derived: sum of 4 quarters · filed 2026-06-15
2024-06-304.15M CAD
10-Q · filed 2025-08-08
8.20M CAD
derived: sum of 2 quarters · filed 2026-06-15
11.90M CAD
derived: sum of 3 quarters · filed 2026-06-15
14.61M CAD
derived: sum of 4 quarters · filed 2026-06-15
2024-03-314.05M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
7.75M CAD
derived: sum of 2 quarters · filed 2026-06-15
10.46M CAD
derived: sum of 3 quarters · filed 2026-06-15
14.18M CAD
10-K · filed 2026-06-15
2023-12-313.69M CAD
10-Q · filed 2025-02-07
6.41M CAD
derived: sum of 2 quarters · filed 2025-02-07
10.13M CAD
10-Q · filed 2025-02-07
14.56M CAD
derived: sum of 4 quarters · filed 2025-05-30
2023-09-302.72M CAD
10-Q · filed 2024-11-08
6.43M CAD
10-Q · filed 2024-11-08
10.86M CAD
derived: sum of 3 quarters · filed 2025-05-30
16.92M CAD
derived: sum of 4 quarters · filed 2025-05-30
2023-06-303.72M CAD
10-Q · filed 2024-08-09
3.87M CAD
10-Q · filed 2023-08-09
8.15M CAD
derived: sum of 2 quarters · filed 2025-05-30
14.20M CAD
derived: sum of 3 quarters · filed 2025-05-30
23.77M CAD
derived: sum of 4 quarters · filed 2025-05-30
2023-03-314.43M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30
10.48M CAD
derived: sum of 2 quarters · filed 2025-05-30
20.06M CAD
derived: sum of 3 quarters · filed 2025-05-30
25.32M CAD
10-K · filed 2025-05-30
31.19M CAD
10-K · filed 2023-06-22
2022-12-316.05M CAD
10-Q · filed 2024-02-09
6.43M CAD
10-Q · filed 2023-02-09
15.63M CAD
derived: sum of 2 quarters · filed 2024-02-09
20.89M CAD
10-Q · filed 2024-02-09
21.73M CAD
10-Q · filed 2023-02-09
31.90M CAD
derived: sum of 4 quarters · filed 2024-05-30
2022-09-309.57M CAD
10-Q · filed 2023-11-09
9.86M CAD
10-Q · filed 2022-11-09
14.84M CAD
10-Q · filed 2023-11-09
15.30M CAD
10-Q · filed 2022-11-09
25.84M CAD
derived: sum of 3 quarters · filed 2024-05-30
32.62M CAD
derived: sum of 4 quarters · filed 2024-05-30
2022-06-305.44M CAD
10-Q · filed 2023-08-09
16.27M CAD
derived: sum of 2 quarters · filed 2024-05-30
23.05M CAD
derived: sum of 3 quarters · filed 2024-05-30
39.00M CAD
derived: sum of 4 quarters · filed 2024-05-30
2022-03-3110.83M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30
17.61M CAD
derived: sum of 2 quarters · filed 2024-05-30
33.56M CAD
derived: sum of 3 quarters · filed 2024-05-30
46.69M CAD
10-K · filed 2024-05-30
47.52M CAD
10-K · filed 2022-05-31
2021-12-316.78M CAD
10-Q · filed 2023-02-09
22.73M CAD
derived: sum of 2 quarters · filed 2023-02-09
35.86M CAD
10-Q · filed 2023-02-09
54.37M CAD
derived: sum of 4 quarters · filed 2023-06-22
2021-09-3015.95M CAD
10-Q · filed 2022-11-09
29.08M CAD
10-Q · filed 2022-11-09
47.60M CAD
derived: sum of 3 quarters · filed 2023-06-22
67.56M CAD
derived: sum of 4 quarters · filed 2023-06-22
2021-06-3013.13M CAD
10-Q · filed 2022-08-09
31.64M CAD
derived: sum of 2 quarters · filed 2023-06-22
51.61M CAD
derived: sum of 3 quarters · filed 2023-06-22
73.59M CAD
derived: sum of 4 quarters · filed 2023-06-22
2021-03-3118.52M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22
38.48M CAD
derived: sum of 2 quarters · filed 2023-06-22
60.46M CAD
derived: sum of 3 quarters · filed 2023-06-22
91.15M CAD
10-K · filed 2023-06-22
2020-12-3119.96M CAD
10-Q · filed 2022-02-09
41.95M CAD
derived: sum of 2 quarters · filed 2022-02-09
72.63M CAD
10-Q · filed 2022-02-09
150.99M CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-09-3021.98M CAD
10-Q · filed 2021-11-08
52.67M CAD
10-Q · filed 2021-11-08
131.02M CAD
derived: sum of 3 quarters · filed 2022-05-31
192.70M CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-06-3030.68M CAD
10-Q · filed 2021-08-06
109.04M CAD
derived: sum of 2 quarters · filed 2022-05-31
170.72M CAD
derived: sum of 3 quarters · filed 2022-05-31
263.60M CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-03-3178.35M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
140.03M CAD
derived: sum of 2 quarters · filed 2022-05-31
232.91M CAD
derived: sum of 3 quarters · filed 2022-05-31
320.28M CAD
10-K · filed 2022-05-31
2019-12-3161.68M CAD
10-Q · filed 2021-02-09
154.56M CAD
derived: sum of 2 quarters · filed 2021-02-09
241.92M CAD
10-Q · filed 2021-02-09
2019-09-3092.88M CAD
10-Q · filed 2020-11-09
180.24M CAD
10-Q · filed 2020-11-09
2019-06-3087.36M CAD
10-Q · filed 2020-08-10
2019-03-31273.45M CAD
10-K · filed 2021-06-01
2018-03-3149.11M CAD
10-K · filed 2020-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87